Publications

[ Author(Asc)] Title Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Liu T, Altman RB.  2015.  Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach. J Chem Inf Model. 55(7):1483-94.
Liang X, Bushman FD, FitzGerald GA.  2015.  Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock. Proc Natl Acad Sci U S A. 112(33):10479-84.
Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, FitzGerald GA.  2015.  Bidirectional interactions between indomethacin and the murine intestinal microbiota.. Elife. 4
Li R, Fries S, Li X, Grosser T, Diamond SL.  2013.  Microfluidic assay of platelet deposition on collagen by perfusion of whole blood from healthy individuals taking aspirin. Clin Chem. 59(8):1195-204.
Li YFuga, Altman RB.  2016.  Systematic Target Function Annotation of Human Transcription Factors. arXiv.
Li YFuga, Xin F, Altman RB.  2016.  SEPARATING THE CAUSES AND CONSEQUENCES IN DISEASE TRANSCRIPTOME. Pac Symp Biocomput. 21:381-92.
Li X, Ballantyne LL, Che X, Mewburn JD, Kang JX, Barkley RM, Murphy RC, Yu Y, Funk CD.  2015.  Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in mice. J Am Heart Assoc. 4(4)
Li X, Fries S, Li R, Lawson JA, Propert KJ, Diamond SL, Blair IA, FitzGerald GA, Grosser T.  2014.  Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 111(47):16830-5.
K
Kuklev DV, Hankin JA, Uhlson CL, Hong YH, Murphy RC, Smith WL.  2013.  Major urinary metabolites of 6-keto-prostaglandin F2α in mice. J Lipid Res. 54(7):1906-14.
Keramati AR, Fathzadeh M, Go G-W, Singh R, Choi M, Faramarzi S, Mane S, Kasaei M, Sarajzadeh-Fard K, Hwa J et al..  2014.  A form of the metabolic syndrome associated with mutations in DYRK1B. N Engl J Med. 370(20):1909-19.
J
Jiang Y, Djuric Z, Sen A, Ren J, Kuklev D, Waters I, Zhao L, Uhlson CL, Hong YH, Murphy RC et al..  2014.  Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila). 7(10):1011-22.
I
Iyengar R, Altman RB, Troyanskya O, FitzGerald GA.  2015.  MEDICINE. Personalization in practice. Science. 350(6258):282-3.
H
Hayer KE, Pizarro A, Lahens NF, Hogenesch JB, Grant GR.  2015.  Benchmark Analysis of Algorithms for Determining and Quantifying Full-length mRNA Splice Forms from RNA-Seq Data. Bioinformatics.
G
Guo L, Worth AJ, Mesaros C, Snyder NW, Glickson JD, Blair IA.  2016.  Diisopropylethylamine/hexafluoroisopropanol-mediated ion-pairing ultra-high-performance liquid chromatography/mass spectrometry for phosphate and carboxylate metabolite analysis: utility for studying cellular metabolism. Rapid Commun Mass Spectrom. 30(16):1835-45.
Griffin JL, Wang X, Stanley E.  2015.  Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics. Circ Cardiovasc Genet. 8(1):187-91.
Grevengoed TJ, Martin SA, Katunga L, Cooper DE, Anderson EJ, Murphy RC, Coleman RA.  2015.  Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function. J Lipid Res. 56(8):1572-82.
Greene CS, Krishnan A, Wong AK, Ricciotti E, Zelaya RA, Himmelstein DS, Zhang R, Hartmann BM, Zaslavsky E, Sealfon SC et al..  2015.  Understanding multicellular function and disease with human tissue-specific networks. Nat Genet. 47(6):569-76.
Goya J, Wong AK, Yao V, Krishnan A, Homilius M, Troyanskaya OG.  2015.  FNTM: a server for predicting functional networks of tissues in mouse. Nucleic Acids Res. 43(W1):W182-7.
Gottlieb A, Altman RB.  2014.  Integrating systems biology sources illuminates drug action. Clin Pharmacol Ther. 95(6):663-9.
Gleim S, Stitham J, Tang WHo, Li H, Douville K, Chelikani P, Rade JJ, Martin KA, Hwa J.  2013.  Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis. PLoS One. 8(6):e67314.
F
Fitzgerald DJ, FitzGerald GA.  2013.  Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism. Circ Res. 112(1):174-94.
D
Dong L, Zou H, Yuan C, Hong YH, Kuklev DV, Smith WL.  2016.  Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis. J Biol Chem. 291(8):4069-78.
Dong L, Sharma NP, Jurban BJ, Smith WL.  2013.  Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer. J Biol Chem. 288(40):28641-55.
C
Chen EP, Markosyan N, Connolly E, Lawson JA, Li X, Grant GR, Grosser T, FitzGerald GA, Smyth EM.  2014.  Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function. Carcinogenesis. 35(8):1788-97.
Chatr-Aryamontri A, Breitkreutz B-J, Oughtred R, Boucher L, Heinicke S, Chen D, Stark C, Breitkreutz A, Kolas N, O'Donnell L et al..  2015.  The BioGRID interaction database: 2015 update. Nucleic Acids Res. 43(Database issue):D470-8.

Pages